Antifungals and probiotics may play a key role in the development of treatment for Crohn's disease

October 4, 2017, Elsevier
Transmission electron microscopy (TEM) showing the bacteria E. coli and S. marcescens surrounding the fungus Candida tropicalis. Credit: Digestive and Liver Disease

Scientists have determined that fungus may play a key role in chronic intestinal inflammation disorders. They found that patients with Crohn's disease tend to have much higher levels of the fungus Candida tropicalis compared to their healthy family members. A new review published in Digestive and Liver Disease looks at these findings and provides insights into potential new therapeutic approaches using antifungals and probiotics in the treatment of inflammatory bowel diseases (IBD) such as Crohn's disease (CD).

"The human gastrointestinal (GI) tract is home to trillions of microorganisms, some beneficial and others potentially harmful. Recent advances in science have allowed us to identify the multitude of organisms inhabiting the GI tract and parse out those that play a role in IBD," explained lead author Mahmoud A. Ghannoum, PhD, of the Center for Medical Mycology, Department of Dermatology, Case Western Reserve University and, University Hospitals Cleveland Medical Center, Cleveland, OH. "Unfortunately, most research has focused on studying only the while overlooking a key player, fungus. In order to address this issue, we have focused our efforts on studying the fungal community in the GI tract known as the mycobiome."

The review centers on a first of its kind study in which researchers characterized the gut bacterial microbiota (bacteriome) and fungal community (mycobiome) in a number of families that had members with CD and healthy relatives. They then defined the microbial interactions leading to microbial imbalance in the suffering from CD. They found that family members with CD had fungal (Candida tropicalis) and bacterial (Serratia marcescens and Escherichia coli) imbalances in their gut's microbiome. Interestingly, they showed that these three organisms worked together to form robust digestive plaque biofilms capable of exacerbating intestinal inflammation.

Scanning electron microscopy (SEM) image of a large biofilm plaque consisting of Candida and bacteria adhering to the intestinal epithelium. Credit: Digestive and Liver Disease

Although the relationship between bacteria and has been recognized not only in our gut, but in our body at large, this study proved for the first time that bacteria and fungi actually work together to exacerbate the inflammatory symptoms in CD. These results provide insight into the roles of bacteria and fungi in CD and may lead to the development of novel treatment approaches and diagnostic tests for CD and other debilitating digestive issues.

Promising potential treatments could include using antifungals and even probiotics that are designed to balance both bacteria and fungi, while breaking down digestive plaque biofilms. Antifungals will control the overgrowth of fungi, while probiotics can help restore and maintain the balance of the microbiota, noted the authors.

"Our ground-breaking discovery that bacteria and fungi both play a critical role in health and has tremendous implications not only for understanding the disease process, but also for development of potentially life changing treatments for those who suffer from chronic digestive diseases," concluded Dr Ghannoum.

Explore further: Single fungus amplifies Crohn's disease symptoms

More information: "The Mycobiome: Role in Health and Disease, and as a Potential Probiotic Target in Gastrointestinal Disease," DOI: 10.1016/j.dld.2017.08.025

Related Stories

Single fungus amplifies Crohn's disease symptoms

June 21, 2017
A microscopic fungus called Candida tropicalis triggered gut inflammation and exacerbated symptoms of Crohn's disease, in a recent study conducted at Case Western Reserve University School of Medicine.

Team identifies fungus in humans for first time as key factor in Crohn's disease

September 20, 2016
A Case Western Reserve University School of Medicine-led team of international researchers has for the first time identified a fungus as a key factor in the development of Crohn's disease. The researchers also linked a new ...

High fat diet reduces gut bacteria, Crohn's disease symptoms

June 22, 2017
Researchers at Case Western Reserve University School of Medicine have shown a high fat diet may lead to specific changes in gut bacteria that could fight harmful inflammation—a major discovery for patients suffering from ...

First systematic study of deadly, antibiotic-resistant fungus reported

February 24, 2017
The deadly fungus, Candida auris, which has been found in hospitals, is resistant to entire classes of antimicrobial drugs, limiting treatment options for those infected. First reported in 2009, the fungus has been linked ...

Intestinal fungi may aid in relief of inflammatory disease

June 23, 2016
Fungi that live in a healthy gut may be as important for good health as beneficial intestinal bacteria, according to new research conducted at Weill Cornell Medicine.

More than just bacteria: The importance of microbial diversity in gut health and disease

March 10, 2014
The gut microbiota contains a vast number of microorganisms from all three domains of life, including bacteria, archaea and fungi, as well as viruses. These interact in a complex way to contribute towards both health and ...

Recommended for you

Lung-on-a-chip simulates pulmonary fibrosis

May 25, 2018
Developing new medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, is not easy.

New blood test to detect liver damage in under an hour

May 24, 2018
A quick and robust blood test that can detect liver damage before symptoms appear has been designed and verified using clinical samples by a team from UCL and University of Massachusetts.

Selective neural connections can be reestablished in retina after injury, study finds

May 24, 2018
The brain's ability to form new neural connections, called neuroplasticity, is crucial to recovery from some types of brain injury, but this process is hard to study and remains poorly understood. A new study of neural circuit ...

Reconstructing Zika's spread

May 24, 2018
The urgent threat from Zika virus, which dominated news headlines in the spring and summer of 2016, has passed for now. But research into how Zika and other mosquito-borne infections spread and cause epidemics is still very ...

Tick bite protection: New CDC study adds to the promise of permethrin-treated clothing

May 24, 2018
The case for permethrin-treated clothing to prevent tick bites keeps getting stronger.

Molecular network boosts drug resistance and virulence in hospital-acquired bacterium

May 24, 2018
In response to antibiotics, a gene regulation network found in the bacterium Acinetobacter baumannii acts to boost both virulence and antibiotic resistance. Edward Geisinger of Tufts University School of Medicine and colleagues ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gzurbay
not rated yet Oct 04, 2017
This appears to be a big deal, it seems quite likely this maybe key to many of the intestinal dis-biome chronic problems ALS - Arthritis - MS - a metabolite that poisons the digestive process...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.